Mark Tebbe, Scientific Advisory Board, Nirogy Therapeutics

Mark J. Tebbe, Ph.D.

Member

Mark has 27 years of experience in drug discovery and development and is a co-inventor of Incivek (Telaprevir), an HCV protease inhibitor as well as numerous other candidates across multiple disease areas. Mark is a serial entrepreneur and was most recently the co-founder and Chief Technology Officer of Quench Bio working on therapies targeting the chronic, aberrant activation of the innate immune system.  Prior to that, he was Head of Drug Discovery at Quartet Medicine working on peripheral neuropathic pain.  His first biotech role was as VP of Medicinal and Computational Chemistry at Forma Therapeutics where he focused on small molecule cancer therapeutics. Prior to joining biotech, Mark held positions of increasing responsibility during his 16-year career at Eli Lilly including head of chemistry in Hamburg, Germany and Research Triangle Park, North Carolina as well as Global Head of Operations for the discovery chemistry group. He obtained his Ph.D. in organic chemistry from Stanford University and his undergraduate degree from the University of Notre Dame.

Ronald DePinho, M.D.

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.

FOUNDER

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat